Precision medicine in the context of lung cancer represents a transformative approach that integrates prevention, diagnosis, and treatment tailored to individual patient differences. This field ...

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...

Merck's (MRK) antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed ...

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Luye Pharma Group (HK:2186) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

Pharma Mar SA (ES:PHM) has released an update. Pharma Mar SA’s partner, Luye Pharma Group, has secured conditional approval from China’s National ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

The trials are evaluating an individualized neoantigen vaccine with Keytruda as an adjuvant therapy for non-small cell lung cancer.

Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...

Doctors have potent new weapons against the deadliest cancer in America and they want to make sure they're on the radar of ...

Novocure has cleared a phase 3 clinical study in pancreatic cancer, showing its tumor-treating electric fields could help ...